• Deutsch
Login

Open Access

  • Home
  • Search
  • Browse
  • Publish
  • FAQ

Refine

Author

  • Koch, Benjamin Florian (12)
  • Koch, Benjamin (8)
  • Bleicher, Marcus (6)
  • Geiger, Helmut (6)
  • Baer, Patrick (5)
  • Koch, Ina (5)
  • Schubert, Ralf (5)
  • Ackermann, Jörg (3)
  • Baer, Patrick C. (3)
  • Stöcker, Horst (3)
+ more

Year of publication

  • 2018 (5)
  • 2020 (4)
  • 2005 (3)
  • 2006 (3)
  • 2019 (3)
  • 2021 (3)
  • 2007 (2)
  • 2016 (2)
  • 2022 (2)
  • 2013 (1)
+ more

Document Type

  • Article (22)
  • Preprint (6)
  • Doctoral Thesis (2)

Language

  • English (29)
  • German (1)

Has Fulltext

  • yes (30)

Is part of the Bibliography

  • no (30)

Keywords

  • mesenchymal stromal/stem cells (4)
  • Diagnostic markers (2)
  • adipose-derived stromal/stem cells (2)
  • cytokines (2)
  • extracellular vesicles (2)
  • hypoxia (2)
  • proteomics (2)
  • ADD (1)
  • Antibiotics (1)
  • Artificial intelligence (1)
+ more

Institute

  • Medizin (18)
  • Physik (8)
  • Frankfurt Institute for Advanced Studies (FIAS) (3)
  • Informatik (2)
  • Informatik und Mathematik (2)
  • Biowissenschaften (1)
  • Exzellenzcluster Makromolekulare Komplexe (1)
  • Georg-Speyer-Haus (1)
  • Pharmazie (1)

30 search hits

  • 1 to 10
  • 10
  • 20
  • 50
  • 100

Sort by

  • Year
  • Year
  • Title
  • Title
  • Author
  • Author
Black hole production and graviton emission in models with large extra dimensions (2007)
Koch, Benjamin
This thesis studies the possible production of microscopical black holes and the emission of graviational radiation under the assumption of large extra dimensions. We derive observables for the Large Hadron Collider and for ultra high energetic cosmic rays.
An introduction to mini black holes at LHC (2007)
Stöcker, Horst ; Koch, Benjamin ; Bleicher, Marcus
Relying on the existing estimates for the production cross sections of mini black holes in models with large extra dimensions, we review strategies for identifying those objects at collider experiments. We further consider a possible stable final state of such black holes and discuss their characteristic signatures. Keywords: Black holes
Mini black holes at the LHC : discovery through di-jet suppression, mono-jet emission and a supersonic boom in the quark-gluon plasma in ALICE, ATLAS and CMS (2006)
Betz, Barbara ; Bleicher, Marcus ; Harbach, Ulrich ; Humanic, Thomas J. ; Koch, Benjamin ; Stöcker, Horst
We examine experimental signatures of TeV-mass black hole formation in heavy ion collisions at the LHC. We find that the black hole production results in a complete disappearance of all very high p_T (> 500 GeV) back-to-back correlated di-jets of total mass M > M_f ~ 1 TeV. We show that the subsequent Hawking-decay produces multiple hard mono-jets and discuss their detection. We study the possibility of cold black hole remnant (BHR) formation of mass ~ M_f and the experimental distinguishability of scenarios with BHRs and those with complete black hole decay. Finally we point out that a Heckler-Kapusta-Hawking plasma may form from the emitted mono-jets. In this context we present new simulation data of Mach shocks and of the evolution of initial conditions until the freeze-out.
Signatures for black hole production from hadronic observables at the Large Hadron Collider (2006)
Humanic, Thomas J. ; Koch, Benjamin ; Stöcker, Horst
The concept of Large Extra Dimensions (LED) provides a way of solving the Hierarchy Problem which concerns the weakness of gravity compared with the strong and electro-weak forces. A consequence of LED is that miniature Black Holes (mini-BHs) may be produced at the Large Hadron Collider in p+p collisions. The present work uses the CHARYBDIS mini-BH generator code to simulate the hadronic signal which might be expected in a mid-rapidity particle tracking detector from the decay of these exotic objects if indeed they are produced. An estimate is also given for Pb+Pb collisions.
Gravitational radiation from elastic particle scattering in models with extra dimensions (2005)
Koch, Benjamin ; Bleicher, Marcus
In this paper we derive a formula for the energy loss due to elastic N to N particle scattering in models with extra dimensions that are compactified on a radius R. In contrast to a previous derivation we also calculate additional terms that are suppressed by factors of frequency over compactification radius. In the limit of a large compactification radius R those terms vanish and the standard result for the non compactified case is recovered.
Gravitational radiation from ultra high energy cosmic rays in models with large extra dimensions (2006)
Koch, Benjamin ; Drescher, Hans-Joachim ; Bleicher, Marcus
The effects of classical gravitational radiation in models with large extra dimensions are investigated for ultra high energy cosmic rays (CRs). The cross sections are implemented into a simulation package (SENECA) for high energy hadron induced CR air showers. We predict that gravitational radiation from quasi-elastic scattering could be observed at incident CR energies above 10^9 GeV for a setting with more than two extra dimensions. It is further shown that this gravitational energy loss can alter the energy reconstruction for CR energies E_CR > 5 10^9 GeV.
Black hole remnants at the LHC (2005)
Koch, Benjamin ; Bleicher, Marcus ; Hossenfelder, Sabine
Within the scenario of large extra dimensions, the Planck scale is lowered to values soon accessible. Among the predicted effects, the production of TeV mass black holes at the LHC is one of the most exciting possibilities. Though the final phases of the black hole’s evaporation are still unknown, the formation of a black hole remnant is a theoretically well motivated expectation. We analyze the observables emerging from a black hole evaporation with a remnant instead of a final decay. We show that the formation of a black hole remnant yields a signature which differs substantially from a final decay. We find the total transverse momentum of the black hole event to be significantly dominated by the presence of a remnant mass providing a strong experimental signature for black hole remnant formation.
Trapping black hole remnants (2005)
Hossenfelder, Sabine ; Koch, Benjamin ; Bleicher, Marcus
Large extra dimensions lower the Planck scale to values soon accessible. The production of TeV mass black holes at the LHC is one of the most exciting predictions. However, the final phases of the black hole's evaporation are still unknown and there are strong indications that a black hole remnant can be left. Since a certain fraction of such objects would be electrically charged, we argue that they can be trapped. In this paper, we examine the occurrence of such charged black hole remnants. These trapped remnants are of high interest, as they could be used to closely investigate the evaporation characteristics. Due to the absence of background from the collision region and the controlled initial state, the signal would be very clear. This would allow to extract information about the late stages of the evaporation process with high precision.
The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation (2019)
Vogel, Jens-Uwe ; Schmidt, Sophie ; Schmidt, Daniel ; Rothweiler, Florian ; Koch, Benjamin Florian ; Baer, Patrick ; Rabenau, Holger ; Michel, Detlef ; Stamminger, Thomas ; Michaelis, Martin ; Cinatl, Jindrich
The thrombopoietin receptor agonist eltrombopag was successfully used against human cytomegalovirus (HCMV)-associated thrombocytopenia refractory to immunomodulatory and antiviral drugs. These effects were ascribed to the effects of eltrombopag on megakaryocytes. Here, we tested whether eltrombopag may also exert direct antiviral effects. Therapeutic eltrombopag concentrations inhibited HCMV replication in human fibroblasts and adult mesenchymal stem cells infected with six different virus strains and drug-resistant clinical isolates. Eltrombopag also synergistically increased the anti-HCMV activity of the mainstay drug ganciclovir. Time-of-addition experiments suggested that eltrombopag interfered with HCMV replication after virus entry. Eltrombopag was effective in thrombopoietin receptor-negative cells, and the addition of Fe3+ prevented the anti-HCMV effects, indicating that it inhibits HCMV replication via iron chelation. This may be of particular interest for the treatment of cytopenias after hematopoietic stem cell transplantation, as HCMV reactivation is a major reason for transplantation failure. Since therapeutic eltrombopag concentrations are effective against drug-resistant viruses, and synergistically increase the effects of ganciclovir, eltrombopag is also a drug-repurposing candidate for the treatment of therapy-refractory HCMV diseas.
Pharmacoproteomic characterisation of human colon and rectal cancer (2017)
Frejno, Martin ; Zenezini Chiozzi, Riccardo ; Wilhelm, Mathias ; Koch, Heiner ; Zheng, Runsheng ; Kläger, Susan ; Ruprecht, Benjamin ; Meng, Chen ; Kramer, Karl ; Jarzab, Anna ; Heinzlmeir, Stephanie ; Johnstone, Elaine ; Domingo, Enric ; Kerr, David ; Jesinghaus, Moritz ; Slotta-Huspenina, Julia ; Weichert, Wilko ; Knapp, Stefan ; Feller, Stephan M. ; Kuster, Bernhard
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models for proteome‐guided pre‐clinical drug sensitivity studies are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of > 10,000 proteins using mass spectrometry. Integration with proteomes of 90 CRC patients and matched transcriptomics data defined integrated CRC subtypes, highlighting cell lines representative of each tumour subtype. Modelling the responses of 52 CRC cell lines to 577 drugs as a function of proteome profiles enabled predicting drug sensitivity for cell lines and patients. Among many novel associations, MERTK was identified as a predictive marker for resistance towards MEK1/2 inhibitors and immunohistochemistry of 1,074 CRC tumours confirmed MERTK as a prognostic survival marker. We provide the proteomic and pharmacological data as a resource to the community to, for example, facilitate the design of innovative prospective clinical trials.
  • 1 to 10

OPUS4 Logo

  • Contact
  • Imprint
  • Sitelinks